Crosslinked polyalkyleneimine hydrogels with tunable degradation rates
Details for Australian Patent Application No. 2009214615 (hide)
International Classifications
Event Publications
22 July 2010 PCT application entered the National Phase
PCT publication WO2009/102952 Priority application(s): WO2009/102952
19 August 2010 Alteration of Name
The name of the applicant has been altered to HyperBranch Medical Technology, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009214625-Combination of alpha 7 nicotinic agonists and antipsychotics
2009214608-Method for treating stress urinary incontinence and symptomatic pelvic relaxation
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser